Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11

Posted on January 9th, 2018 by in Pharma R&D

Healthcare companies and investors are flocking to San Francisco from January 8-11 for the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel. Continue reading “Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11” »

Seeking Other Perspectives to Tease Out New Innovations

Posted on November 22nd, 2017 by in Pharma R&D

On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. Continue reading “Seeking Other Perspectives to Tease Out New Innovations” »

The Power of Two in Lead Optimization

Posted on July 3rd, 2017 by in Chemistry

The rise of in silico approaches has revolutionized early drug discovery, making it possible to model the potential in vivo behaviors of large numbers of compounds, delve deep into their bioactive and chemical properties, Continue reading “The Power of Two in Lead Optimization” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »